Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
FDA OKs Zolbetuximab for Gastric, Gastroesophageal Cancer
FDA also approved the Ventana CLDN18 (43-14A) RxDx Assay, from Ventana Medical Systems, Inc. and Roche Diagnostics, to identify claudin 18.2–positive tumors and thus patients who may be eligible to receive zolbetuximab.
FDA approves Astellas' gastric cancer therapy
The U.S. Food and Drug Administration approved Astellas' therapy to treat a type of gastric cancer, the health regulator's website showed on Friday.
Novel Targeted Drug Approved for Stomach Cancers
The FDA approved zolbetuximab (Vyloy), a claudin 18.2 (CLDN18.2)-directed cytolytic antibody, in combination with chemotherapy for the first-line treatment of adults with advanced HER2-negative gastric or gastroesophageal junction (GEJ) adenocarcinoma,
Astellas nabs class-first FDA approval for CLDN18.2 gastric cancer med Vyloy
After a prior rejection, Astellas can head into the weekend celebrating a class-first FDA approval for its new gastric cancer med Vyloy. | Astellas' Vyloy won an FDA approval to treat gastric or gastroesophageal junction adenocarcinoma patients whose tumors are CLDN18.
Astellas Pharma's VYLOY Receives FDA Approval For Treatment Of Advanced Gastric And GEJ Cancer
Astellas Pharma Inc. (ALPMY, ALPMY) said that the U.S. Food and Drug Administration has approved VYLOY (zolbetuximab-clzb) in
Astellas Pharma Inc.: Astellas' VYLOY (zolbetuximab-clzb) Approved by U.S. FDA for Treatment of Advanced Gastric and GEJ Cancer
VYLOY is the first and only CLDN18.2-targeted treatment approved in the U.S. for adults with advanced gastric and gastroesophageal junction cancer whose tumors are CLDN18.2 positive TOKYO, Oct. 18
Astellas' VYLOYâ„¢ (zolbetuximab-clzb) Approved by U.S. FDA for Treatment of Advanced Gastric and GEJ Cancer
Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced that the U.S. Food and Drug Administration (FDA) has approved VYLOYâ„¢ (zolbetuximab-clzb) in combination with fluoropyrimidine- and platinum-containing chemotherapy for the first-line treatment of adults with locally advanced unresectable or metastatic human epidermal growth factor receptor 2 (HER2)-negative gastric or gastroesophageal junction (GEJ) adenocarcinoma whose tumors are claudin (CLDN) 18.
Astellas Pharma's Cancer Drug Vyloy Gets FDA Approval
Astellas Pharma's drug Vyloy was approved for treatment of advanced gastric and gastroesophageal junction cancer by the Food and Drug Administration. The pharmaceutical company said Friday the FDA approved the drug for use in combination with fluoropyrimidine-and-platinum-containing chemotherapy.
4d
on MSN
Clinical trials confirm zolbetuximab's efficacy in gastric cancer
In Germany, around 17,000 people are diagnosed with gastric cancer every year. The disease is one of the leading causes of ...
Knowridge
1d
Scientists find new treatment for gastric cancer
In Germany, around 17,000 people are diagnosed with gastric cancer every year, and it remains one of the deadliest cancers, ...
technologynetworks
4d
Drug Extends Lifespan in Gastric Cancer Clinical Trial
In Germany, around 17,000 people are diagnosed with gastric cancer every year. The disease is one of the leading causes of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Trending now
Judge unseals new evidence
Preliminary cause of death
Frozen waffles recalled
Nationwide blackout in Cuba
Republicans appeal ruling
Ex-MN congressman dies
La Nina could arrive soon
NC breaks turnout record
Challenges military listing
Emergency abortion ruling
NK sending troops to RU?
Bladder cancer drug pulled
US charges ex-Indian spy
Antitrust ruling delayed
Opioid suits settlement deal
Probes near miss in Austin
$4M LAPD fentanyl seizure
‘Full Self-Driving’ probe
PG&E shuts off power
FAA opens new safety review
Musk's first Trump event
At decade-high level
To furlough 700 workers
Teen tobacco use falls
School shooting report
Nevada US Senate debate
Eases voting rules
Fire prompts evacuations
Three Americans detained
OK classroom Bible suit
Related topics
Vyloy
gastric cancer
Food and Drug Administration
Astellas Pharma
Feedback